NHS England announced a safer alternative to treating retinopathy of prematurity (ROP) in premature infants, available following the publication of new national NHS guidance.
The drug ranibizumab, delivered through a precise injection system that prevents scarring, has replaced the current standard of care of laser treatment for some forms of ROP.
NHS chief executive Amanda Pritchard said: ‘The national rollout of this lifeline treatment for babies who are too poorly to undergo laser therapy is a vital step forward in preventing avoidable vision loss.
Health minister Neil O’Brien added: ‘We are committed to eliminating avoidable blindness and have appointed a national clinical director for eye care who will help us make sure patients receive the care they need, and we continue to invest in and train our ophthalmology workforce.’
